Key Points- Bristol Myers Squibb has sued the Biden administration over Medicare’s new powers to negotiate drug prices under the Inflation Reduction Act.- The drugmaker said its blood thinner Eliquis will be subject to the negotiations later this year.- Bristol Myer Squibb’s complaint mirrors the arguments made last week by Merck, the first company to […]